The Government has commissioned the second part of a review into the use of cannabis as a medicinal product after the Chief Medical Officer of England concluded there was evidence of "therapeutic benefit" for some conditions, Downing Street has said.
Home Secretary Sajid Javid ordered part one of the review last month following a number of high-profile cases involving children being denied access to cannabis oil to control epileptic seizures.
The Prime Minister's official spokesman said: "Professor Dame Sally Davies examined existing research into therapeutic and medicinal benefits of cannabis-related products.
"This has led today to the commissioning of the second part of the review that will be completed by the Advisory Council on the Misuse of Drugs.
"The ACMD will be advising on whether cannabis-related medicinal products should be re-scheduled within the next three weeks."